Finally, in the unforeseen event where TLRY stockholders don’t approve the merger with APHA, Aphria looks like a good buy based on its standalone financials. Its gross margins are almost 2.5x that of Tilray. Looking at valuations, APHA trades at an NTM EV-to-revenue multiple of 8.2x compared to 11x for TLRY. To sum it up, APHA stock looks undervalued ahead of its merger with TLRY and looks like a good buy now.
View more information: https://marketrealist.com/p/buy-aphria-apha-stock-before-tlry-merger/